Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2012 | 1 |
2019 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
The neuropathology of genetic Parkinson's disease.
Mov Disord. 2012 Jun;27(7):831-42. doi: 10.1002/mds.24962. Epub 2012 Mar 26.
Mov Disord. 2012.
PMID: 22451330
Free PMC article.
Review.
Pathological data from autopsies genotyped for Parkinson's disease (PD)-related mutations in alpha-synuclein, Parkin, PINK1, DJ1, LRRK2, and glucocerebrosidase have accumulated in recent years. ...Pathological data from DJ1 mutation carriers, nonmanifesting mutation carrie …
Pathological data from autopsies genotyped for Parkinson's disease (PD)-related mutations in alpha-synuclein, Parkin, PINK1, DJ1, LRR …
NPRL3 loss alters neuronal morphology, mTOR localization, cortical lamination and seizure threshold.
Iffland PH, Everett ME, Cobb-Pitstick KM, Bowser LE, Barnes AE, Babus JK, Romanowski AJ, Baybis M, Elziny S, Puffenberger EG, Gonzaga-Jauregui C, Poulopoulos A, Carson VJ, Crino PB.
Iffland PH, et al.
Brain. 2022 Nov 21;145(11):3872-3885. doi: 10.1093/brain/awac044.
Brain. 2022.
PMID: 35136953
Free PMC article.
The NPRL3 pedigree exhibited an epilepsy penetrance of 28% and heterogeneous clinical phenotypes with a range of epilepsy semiologies, i.e. focal or generalized onset, brain imaging abnormalities, i.e. polymicrogyria, focal cortical dysplasia or normal imaging, and EEG findings, …
The NPRL3 pedigree exhibited an epilepsy penetrance of 28% and heterogeneous clinical phenotypes with a range of epilepsy semiologies, i.e. …
Item in Clipboard
The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBD.
Bamias G, Kokkotis G, Christidou A, Christodoulou DK, Delis V, Diamantopoulou G, Fessatou S, Gatopoulou A, Giouleme O, Kafritsa P, Kalantzis C, Kapsoritakis A, Karatzas P, Karmiris K, Katsanos K, Kevrekidou P, Kosmidis C, Mantaka A, Mathou N, Michalopoulos G, Michopoulos S, Papaconstantinou I, Papatheodoridis G, Polymeros D, Potamianos S, Poulopoulos G, Protopapas A, Sklavaina M, Soufleris K, Theocharis G, Theodoropoulou A, Triantafillidis JK, Triantafyllou K, Tsiolakidou G, Tsironi E, Tzouvala M, Viazis N, Xourgias V, Zacharopoulou E, Zampeli E, Mantzaris GJ.
Bamias G, et al.
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e810-e817. doi: 10.1097/MEG.0000000000002267.
Eur J Gastroenterol Hepatol. 2021.
PMID: 34402469
Free PMC article.
Item in Clipboard
Photocatalytic treatment of organic pollutants in a synthetic wastewater using UV light and combinations of TiO2, H2O2 and Fe(III).
Poulopoulos SG, Yerkinova A, Ulykbanova G, Inglezakis VJ.
Poulopoulos SG, et al.
PLoS One. 2019 May 15;14(5):e0216745. doi: 10.1371/journal.pone.0216745. eCollection 2019.
PLoS One. 2019.
PMID: 31091256
Free PMC article.
It was shown that the process applied was effective in treating the wastewater for initial total carbon 32 mg L-1, 0.5 g L-1 TiO2, and 66.6 mg L-1 H2O2. Applying UV/TiO2 and UV/H2O2, 58% and 53% total carbon removals were achieved, respectively, but combining TiO2 and H2O2 …
It was shown that the process applied was effective in treating the wastewater for initial total carbon 32 mg L-1, 0.5 g L-1 TiO2, an …
Item in Clipboard
The natural history of the non-nephrotic membranous nephropathy patient.
Hladunewich MA, Troyanov S, Calafati J, Cattran DC; Metropolitan Toronto Glomerulonephritis Registry.
Hladunewich MA, et al.
Clin J Am Soc Nephrol. 2009 Sep;4(9):1417-22. doi: 10.2215/CJN.01330209. Epub 2009 Aug 6.
Clin J Am Soc Nephrol. 2009.
PMID: 19661220
Free PMC article.
The only distinguishing baseline feature between the two groups was a higher level of urine protein in the group that subsequently developed nephrotic syndrome (1.98 [0.3 to 3.4] versus 2.43 [0.5 to 3.4] g/d). CONCLUSIONS: Patients with MGN and sustained subnephrotic range …
The only distinguishing baseline feature between the two groups was a higher level of urine protein in the group that subsequently developed …
Item in Clipboard
Cite
Cite